Back to top

gene-editing: Archive

Zacks Equity Research

CRISPR (CRSP) to Begin Clinical Study on Diabetes Therapy Drug

CRISPR Therapeutics (CRSP) receives clearance from Health Canada to initiate clinical studies for VCTX210, its investigational therapy for the treatment of type 1 diabetes.

VRTXNegative Net Change CRSPPositive Net Change SYBXNegative Net Change DTILPositive Net Change